Objective To observe the role of the donor specific antibody(DSA) and human leukocyte antigen(HLA) antibody in pediatric liver transplantation. Methods The clinical data of liver transplantation cases in some children (aged below 18 years) that were performed between Sep 1 2016 and Dec 31 2016 in Tianjin First Central Hospital,were analyzed retrospectively. HLA antibodies were detected by Luminex before liver transplantation, 1 week after surgery and 3 months after surgery. HLA typing was detected in HLA antibody positive specimens. The incidences of rejection, cytomegalovirus (CMV) infection, EB virus infection, vascular complications and biliary complications after liver transplantation were observed. Results A total number of 11 cases were included. DSA was found positive in 1 case before liver transplantation, and in 1 case after liver transplantation. HLA antibodies of 2 cases were positive (non-DSA) before liver transplantation and negative after liver transplantation. The tests for HLA antibody of 1 case were positive before liver transplantation,one week and 3 months after operation. The HLA antibody in 1 case was positive 1 week after liver transplantation. HLA antibody in 5 cases was negative before and after liver transplantation. The average follow-up time of 11 patients was 15.3±1.9 months. All patientssurvived and no rejection was observed after liver transplantation. One case presented hepatic artery thrombosis on the third day and hepatobiliary anastomostic bile leakage occurred on the sixth day after liver transplantation. One case of anastomotic stenosis was found on the third day after liver transplantation. There were two cases of Cytomegalovirus infection and one case of EB virus infection after surgery. Conclusion Detection of DSA and HLA antibody in the early period of pediatric liver transplantation complications.has a certain significant